Mostrar el registro sencillo del ítem

dc.contributor.authorRodon, Jordi
dc.contributor.authorMykytyn, Anna Z.
dc.contributor.authorCantero, Guillermo
dc.contributor.authorAlbulescu, Irina C.
dc.contributor.authorBosch, Berend-Jan
dc.contributor.authorBrix, Alexander
dc.contributor.authorAudonnet, Jean-Christophe
dc.contributor.authorBensaid, Albert
dc.contributor.authorVergara-Alert, Júlia
dc.contributor.authorHaagmans, Bart L.
dc.contributor.authorSegalés, Joaquim
dc.contributor.otherProducció Animalca
dc.date.accessioned2022-09-27T08:26:05Z
dc.date.available2022-09-27T08:26:05Z
dc.date.issued2022-06-24
dc.identifier.citationRodon, Jordi, Anna Z. Mykytyn, Guillermo Cantero, Irina C. Albulescu, Berend-Jan Bosch, Alexander Brix, and Jean-Christophe Audonnet et al. 2022. "Protective Efficacy Of An RBD-Based Middle East Respiratory Syndrome Coronavirus (MERS-Cov) Particle Vaccine In Llamas". One Health Outlook 4 (1). doi:10.1186/s42522-022-00068-9.ca
dc.identifier.issn2524-4655ca
dc.identifier.urihttp://hdl.handle.net/20.500.12327/1922
dc.description.abstractOngoing outbreaks of Middle East respiratory syndrome coronavirus (MERS-CoV) continue posing a global health threat. Vaccination of livestock reservoir species is a recommended strategy to prevent spread of MERS-CoV among animals and potential spillover to humans. Using a direct-contact llama challenge model that mimics naturally occurring viral transmission, we tested the efficacy of a multimeric receptor binding domain (RBD) particle-display based vaccine candidate. While MERS-CoV was transmitted to naïve animals exposed to virus-inoculated llamas, immunization induced robust virus-neutralizing antibody responses and prevented transmission in 1/3 vaccinated, in-contact animals. Our exploratory study supports further improvement of the RBD-based vaccine to prevent zoonotic spillover of MERS-CoV.ca
dc.format.extent5ca
dc.language.isoengca
dc.publisherBMCca
dc.relation.ispartofOne Health Outlookca
dc.rightsAttribution 4.0 Internationalca
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleProtective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamasca
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.relation.projectIDEC/PF7/115760/EU/Zoonotic Anticipation and Preparedness Initiative/ZAPIca
dc.relation.projectIDEC/H2020/731014/EU/Veterinary Biocontained facility Network for excellence in animal infectiology research and experimentation /VetBioNetca
dc.subject.udc619ca
dc.identifier.doihttps://doi.org/10.1186/s42522-022-00068-9ca
dc.contributor.groupSanitat Animalca


Ficheros en el ítem

 
 

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution 4.0 International
Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by/4.0/
Compartir en TwitterCompartir en LinkedinCompartir en FacebookCompartir en TelegramCompartir en WhatsappImprimir